Search for: "Bristol-Myers Company v. FTC"
Results 1 - 13
of 13
Sorted by Relevance
|
Sort by Date
15 Aug 2006, 6:45 am
See earlier posts from the Patent Baristas: Apotex To Launch Generic Plavix At Its Own Risk FTC Rejects Patent Deal by Bristol-Myers and Sanofi Does Sanofi-Aventis Patent Settlement With Apotex Reveal a Trend? [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
31 Aug 2006, 6:15 pm
See earlier posts from the Patent Baristas: Update: Sanofi and Bristol-Myers File for Preliminary Injunction Against Apotex Apotex To Launch Generic Plavix At Its Own Risk FTC Rejects Patent Deal by Bristol-Myers and Sanofi Does Sanofi-Aventis Patent Settlement With Apotex Reveal a Trend? [read post]
25 Apr 2010, 5:52 pm
Bristol-Myers Squibb Co. [read post]
27 Apr 2009, 9:43 am
BRISTOL-MYERS SETTLES PLAVIX COVER-UP CLAIMS FOR $2.1 MILLION, FTC v. [read post]
28 Apr 2008, 11:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC vacates FTC’s decision that Rambus breached antitrust duty by violating JEDEC patent disclosure rules and orders new trial: (Philip Brooks), (Techdirt), (Ars Technica), (IP Law360), (Peter Zura's 271 Patent Blog), (Hal Wegner), (IPBiz), (IP Law360), UK Court of Appeal rules on whether prior art not in the same design… [read post]
31 Dec 2015, 5:12 am
Yates v. [read post]
27 Feb 2009, 7:00 am
(Techdirt) How companies can cash in on innovations and patents (IP Frontline) International Property Rights Index 2009 - New report identifies world’s most IP-friendly country, but trade marks are ignored (IAM) What do clients want? [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO:… [read post]
